Rocky Mountain Leukemia, Lymphoma & Myeloma Summit - Precision. Progress. Practice. conference hero image

Rocky Mountain Leukemia, Lymphoma & Myeloma Summit - Precision. Progress. Practice.

Accreditation: 9.00 AMA PRA Category 1 Credit™ | 9.00 ABIM MOC II | 9.00 Nursing Contact Hours | 9.00 ACPE Pharmacy

Venue: Hyatt Regency Salt Lake City, 170 South West Temple Street, Salt Lake City, UT, 84101, United States

Start Date: End Date:
Register for Conference

Official conference page for Rocky Mountain Leukemia, Lymphoma & Myeloma Summit - Precision. Progress. Practice..

About Rocky Mountain Leukemia, Lymphoma & Myeloma Summit - Precision. Progress. Practice.

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

Srinivas Tantravahi
Amy Sharp
31+

Faculty and committee

Our Speakers

Conference program and agenda

Agenda

Day 1: Friday, September 18th, 2026

All timings are in Mountain Time (MDT, GMT-06:00) time.

12:00 PM - 01:00 PMRegistration, Lunch & Exhibits
01:00 PM - 01:05 PMWelcome
01:05 PM - 02:35 PMSession 1: Acute Leukemia

Session Chair: Srinivas Tantravahi, MBBS

01:05 PM - 01:20 PM

How I Treat Acute Myeloid Leukemia in 2026

01:20 PM - 01:35 PM

How I Treat Acute Lymphoblastic Leukemia in 2026 Adam DuVall, MD

01:35 PM - 01:45 PM

Case Presentation: The Gray Zone – Controversy and Clinical Judgement in Acute Leukemia Sankalp Arora

01:45 PM - 02:35 PM

Q&A and Discussion

Moderators:

Srinivas Tantravahi, MBBS

Panelists:

Adam DuVall, MD; Zaker Schwabkey, MD; Sankalp Arora

02:35 PM - 02:50 PMBreak and Exhibits
02:50 PM - 04:20 PMSession 2: Aggressive Lymphoma

Session Chair: Daniel Arthur Ermann, MD

02:50 PM - 03:05 PM

Evolving Treatment Landscape in Newly Diagnosed Large B-Cell Lymphoma Harsh Shah, DO

03:05 PM - 03:20 PM

How I Treat R/R Large B-Cell Lymphoma in 2026 Richard T. Maziarz, MD

03:20 PM - 04:00 PM

Panel Discussion: Practical Decision-Making in Community Practice

03:50 PM - 04:20 PM

Case Presentation: The Gray Zone – Controversy and Clinical Judgement in Acute Leukemia

04:00 PM - 04:20 PM

Case Based Panel Discussion

Moderators:

Daniel Arthur Ermann, MD

Panelists:

Richard T. Maziarz, MD; Banu Symington, MD; Harsh Shah, DO

04:20 PM - 04:20 PMAdjourn Day 1

Day 2: Saturday, September 19th, 2026

07:00 AM - 08:00 AMRegistration, Breakfast, and Exhibits
08:00 AM - 08:05 AMWelcome
08:05 AM - 08:25 AMBinaytara’s Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA
08:25 AM - 09:55 AMSession 3A: Low-grade Lymphoma & CLL

Session Chair: Xylina Gregg, MD

08:25 AM - 08:40 AM

How I Treat Indolent Lymphoma in 2026 Narendranath Epperla, MD

08:40 AM - 08:55 AM

How I Treat Chronic Lymphocytic Leukemia (CLL) in 2026 Daniel Arthur Ermann, MD

08:55 AM - 09:05 AM

Q&A and Discussion

09:05 AM - 09:15 AM

Case Presentation: The Gray Zone – Controversy and Clinical Judgement in Low-grade Lymphoma & CLL

09:15 AM - 09:55 AM

Case Discussion: The Gray Zone – Controversy and Clinical Judgement in Low-grade Lymphoma & CLL

Moderators:

Xylina Gregg, MD

Panelists:

Narendranath Epperla, MD; Daniel Arthur Ermann, MD

09:05 AM - 09:55 AMSession 3B: CAR-T and Cellular Therapy Toxicity Management

Session Chair: Amanda Dailey-Hansen, DNP

09:05 AM - 09:25 AM

CAR-T Toxicity Christopher Cahoon, PharmD

09:25 AM - 09:55 AM

Q&A and Discussion

Moderators:

Amanda Dailey-Hansen, DNP

Panelists:

Christopher Cahoon, PharmD; Brian Burnham, PharmD; Amy Maggie Sharp, BSN

09:55 AM - 10:25 AMBreaks & Exhibits

Venue and map

Accreditations and continuing education

Registration and pricing

Exhibitors and sponsorship